Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Treasury Shares (2019 - 2025)

Korro Bio (KRRO) has disclosed Treasury Shares for 4 consecutive years, with $1.9 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Treasury Shares changed N/A year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Sep 2023, changed N/A, and an annual FY2022 reading of $2902.0, down 99.54% over the prior year.
  • Treasury Shares was $1.9 million for Q3 2023 at Korro Bio, down from $3.1 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.6 million in Q1 2023 and bottomed at $2629.0 in Q1 2021.
  • Average Treasury Shares over 4 years is $918337.9, with a median of $5600.0 recorded in 2020.
  • The sharpest move saw Treasury Shares surged 20148.95% in 2021, then plummeted 99.54% in 2022.
  • Year by year, Treasury Shares stood at $3093.0 in 2020, then soared by 20148.95% to $626300.0 in 2021, then tumbled by 99.54% to $2902.0 in 2022, then soared by 66411.03% to $1.9 million in 2023.
  • Business Quant data shows Treasury Shares for KRRO at $1.9 million in Q3 2023, $3.1 million in Q2 2023, and $3.6 million in Q1 2023.